Search
Kiora Pharmaceuticals Inc
KPRXAdd to Watchlist
2.290USD
-0.030-1.29%
Close 10-22 16:00（ET）
10.12MMarket Cap
LossP/E TTM
Kiora Pharmaceuticals Inc (KPRX) Stock Price Target & Forecast
Analyst Rating
Based on 1 analysts giving stock ratings to Kiora Pharmaceuticals Inc in the past month.
Buy
0 Strong Buy
1 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
12.000USD+400.00%
KPRX Analyst Recommendation Trends
In the current month, KPRX has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. KPRX average Analyst price target in the last month is 12.000.
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
KPRX Analyst Rating for Peer Comparison
Updated: Oct 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Insmed Inc
INSM
7
18
0
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ionis Pharmaceuticals Inc
IONS
6
14
5
0
0
25
Kymera Therapeutics Inc
KYMR
9
13
2
0
0
24
Biontech SE
BNTX
4
12
8
0
0
24
IQVIA Holdings Inc
IQV
8
12
3
0
0
23
Cytokinetics Inc
CYTK
5
16
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Financial Forecasting
Based on analysts' estimates, KPRX EPS is projected to reach -0.380 in FY2026Q3, following reported EPS of -0.337 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.67
-0.71
-0.62
-0.38
-0.42
Actual
-1.56
-0.58
-0.34
--
--
Surprise
-133.24%
+18.42%
+45.72%
--
--
FAQs
What is Kiora Pharmaceuticals Inc's expected revenue for the next quarter?
Kiora Pharmaceuticals Inc's expected revenue is 1.50M.
What is Kiora Pharmaceuticals Inc's price target?
Analysts forecast that Kiora Pharmaceuticals Inc's price target is USD 12.00, with the highest forecast at USD 12.00 and the lowest forecast at USD 12.00.
How have Kiora Pharmaceuticals IncKPRX's recent earnings per share performed?
The market expectation was USD -0.34, while Kiora Pharmaceuticals IncKPRX's earnings per share (EPS) for the previous quarter was USD -0.58. EPS for the next quarter is expected at USD -0.38.
What is the analyst rating for Kiora Pharmaceuticals Inc?
Based on the ratings of Kiora Pharmaceuticals Inc's stock from 1 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.